At a glance
- Originator GlaxoSmithKline
- Developer GSK
- Class Antivirals; Nucleosides; Small molecules
- Mechanism of Action DNA-directed DNA polymerase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Epstein-Barr virus infections; Herpes simplex virus infections; Varicella zoster virus infections
Most Recent Events
- 02 Mar 2001 Profile reviewed but no significant changes made
- 14 Jul 1998 No-Development-Reported for Epstein-Barr virus infections in United Kingdom (Unknown route)
- 14 Jul 1998 No-Development-Reported for Herpes simplex virus infections in United Kingdom (Unknown route)